Roche said CR-388 is ready to start phase 2 testing and will be developed for the treatment of obesity in people with and without type 2 diabetes. Like Zepbound and Novo Nordisk’s rival obesity ...
there are approximately 2.3 million new cases each year, and each year over 620,000 breast cancer patients will die. Roche’s PATHWAY anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody test ...
Ich danke allen, die diese Einigung möglich gemacht haben.“ Jörg Garske, Sprecher der Bürgerinitiative Hamburg Bau 2.0, ergänzt: „Mit der Freistellung der Innenräume und dem pragmatischen Ansatz zum ...
Das Bundeskanzleramt unter Olaf Scholz weigert sich, seine Akten über die Genehmigung und den Bau der umstrittenen Ostsee-Pipeline Nord Stream 2 offenzulegen. Scholz war als Finanzminister ...
Nintendo Switch 2 is finally confirmed. After literal years of unverified rumors, dubious leaks and copious amounts of online speculation, Nintendo has lifted the lid on its next-generation ...
Merck's injected version of its blockbuster cancer drug Keytruda could face a potential patent challenge from biotech Halozyme Therapeutics , the Wall Street Journal reported on Wednesday, citing ...
It looks like you're using an old browser. To access all of the content on Yr, we recommend that you update your browser. It looks like JavaScript is disabled in your browser. To access all the ...
It looks like you're using an old browser. To access all of the content on Yr, we recommend that you update your browser. It looks like JavaScript is disabled in your browser. To access all the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback